IHH Healthcare Share Price

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 23:00:00 18/07/2024 BST 5-day change 1st Jan Change
6.33 MYR -0.16% Intraday chart for IHH Healthcare 0.00% +4.98%

Financials

Sales 2024 * 22.46B 4.79B 371B Sales 2025 * 24.02B 5.13B 397B Capitalization 55.75B 11.9B 921B
Net income 2024 * 1.88B 402M 31.14B Net income 2025 * 2.03B 433M 33.53B EV / Sales 2024 * 2.82 x
Net Debt 2024 * 7.55B 1.61B 125B Net Debt 2025 * 6.41B 1.37B 106B EV / Sales 2025 * 2.59 x
P/E ratio 2024 *
30.3 x
P/E ratio 2025 *
28.1 x
Employees 70,000
Yield 2024 *
1.26%
Yield 2025 *
1.32%
Free-Float 23.99%
More Fundamentals * Estimated data
Dynamic Chart
1 day-0.16%
Current month+0.48%
1 month+1.44%
3 months+3.43%
6 months+5.50%
Current year+4.98%
More quotes
1 week
6.31
Extreme 6.31
6.39
1 month
6.15
Extreme 6.15
6.39
Current year
5.93
Extreme 5.93
6.43
1 year
5.72
Extreme 5.72
6.43
3 years
5.44
Extreme 5.44
7.34
5 years
4.55
Extreme 4.55
7.34
10 years
4.54
Extreme 4.54
7.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 30/09/23
Investor Relations Contact - -
Corporate Officer/Principal 58 30/04/21
Members of the board TitleAgeSince
Director/Board Member 67 23/01/12
Director/Board Member 64 31/12/20
Director/Board Member 66 15/05/11
More insiders
Date Price Change Volume
19/07/24 6.33 -0.16% 4,294,400
18/07/24 6.34 -0.16% 4,371,500
17/07/24 6.35 0.00% 2,283,300
16/07/24 6.35 +0.16% 3,649,100
15/07/24 6.34 +0.16% 7,070,400

End-of-day quote BURSA MALAYSIA, July 18, 2024

More quotes
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
6.33 MYR
Average target price
7.26 MYR
Spread / Average Target
+14.68%
Consensus